ATE286734T1 - Verwendung von progesteronrezeptor antagonisten zur verhütung oder behinderung der fertilisation - Google Patents

Verwendung von progesteronrezeptor antagonisten zur verhütung oder behinderung der fertilisation

Info

Publication number
ATE286734T1
ATE286734T1 AT01117955T AT01117955T ATE286734T1 AT E286734 T1 ATE286734 T1 AT E286734T1 AT 01117955 T AT01117955 T AT 01117955T AT 01117955 T AT01117955 T AT 01117955T AT E286734 T1 ATE286734 T1 AT E286734T1
Authority
AT
Austria
Prior art keywords
progesterone receptor
prevent
receptor antagonists
inhibit fertilization
fertilization
Prior art date
Application number
AT01117955T
Other languages
English (en)
Inventor
Garry D Hodgen
Original Assignee
Eastern Virginia Med School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Med School filed Critical Eastern Virginia Med School
Application granted granted Critical
Publication of ATE286734T1 publication Critical patent/ATE286734T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Fats And Perfumes (AREA)
  • Fertilizers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT01117955T 1993-02-19 1994-02-18 Verwendung von progesteronrezeptor antagonisten zur verhütung oder behinderung der fertilisation ATE286734T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization

Publications (1)

Publication Number Publication Date
ATE286734T1 true ATE286734T1 (de) 2005-01-15

Family

ID=21795040

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94910707T ATE218347T1 (de) 1993-02-19 1994-02-18 Kit zur verhütung oder hemmung der befruchtung
AT01117955T ATE286734T1 (de) 1993-02-19 1994-02-18 Verwendung von progesteronrezeptor antagonisten zur verhütung oder behinderung der fertilisation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94910707T ATE218347T1 (de) 1993-02-19 1994-02-18 Kit zur verhütung oder hemmung der befruchtung

Country Status (24)

Country Link
US (1) US5516769A (de)
EP (2) EP0684825B1 (de)
JP (1) JP3054780B2 (de)
KR (1) KR100232833B1 (de)
AT (2) ATE218347T1 (de)
AU (1) AU692150B2 (de)
BG (1) BG62431B1 (de)
BR (1) BR9406666A (de)
CA (1) CA2156493C (de)
CZ (1) CZ294325B6 (de)
DE (2) DE69434239T2 (de)
DK (2) DK0684825T3 (de)
ES (1) ES2231356T3 (de)
FI (1) FI114687B (de)
HU (1) HU221162B1 (de)
NO (1) NO307916B1 (de)
NZ (1) NZ262998A (de)
PL (1) PL175440B1 (de)
PT (2) PT1159965E (de)
RO (1) RO118565B1 (de)
RU (1) RU2139055C1 (de)
SK (1) SK282068B6 (de)
UA (1) UA41351C2 (de)
WO (1) WO1994018982A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) * 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
EA006805B1 (ru) 1999-08-31 2006-04-28 Шеринг Акциенгезельшафт Мезопрогестины (модуляторы рецептора прогестерона) в качестве компонента женских контрацептивов
RU2209634C1 (ru) * 2002-04-29 2003-08-10 Иткес Александр Веньяминович Набор эстроген-рецептор для обнаружения рецепторов к эстрогенам в биопсийных гистологических препаратах (варианты)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
JPH08510992A (ja) 1996-11-19
FI953878A0 (fi) 1995-08-17
NO953242L (no) 1995-08-17
SK282068B6 (sk) 2001-10-08
CZ294325B6 (cs) 2004-11-10
PL310357A1 (en) 1995-12-11
UA41351C2 (uk) 2001-09-17
CA2156493A1 (en) 1994-09-01
EP0684825A4 (de) 1998-01-14
DK0684825T3 (da) 2002-07-15
CZ205095A3 (en) 1996-01-17
BG99867A (bg) 1996-04-30
AU692150B2 (en) 1998-06-04
SK101395A3 (en) 1997-04-09
KR960700726A (ko) 1996-02-24
HU221162B1 (en) 2002-08-28
RU2139055C1 (ru) 1999-10-10
DE69430732D1 (de) 2002-07-11
PL175440B1 (pl) 1998-12-31
NZ262998A (en) 1997-06-24
EP1159965A2 (de) 2001-12-05
BG62431B1 (bg) 1999-11-30
NO953242D0 (no) 1995-08-17
DE69430732T2 (de) 2002-10-24
WO1994018982A1 (en) 1994-09-01
ATE218347T1 (de) 2002-06-15
EP1159965A3 (de) 2002-05-22
FI953878L (fi) 1995-08-17
JP3054780B2 (ja) 2000-06-19
US5516769A (en) 1996-05-14
EP0684825A1 (de) 1995-12-06
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
ES2231356T3 (es) 2005-05-16
FI114687B (fi) 2004-12-15
PT684825E (pt) 2002-10-31
AU6299294A (en) 1994-09-14
EP0684825B1 (de) 2002-06-05
NO307916B1 (no) 2000-06-19
PT1159965E (pt) 2005-03-31
RO118565B1 (ro) 2003-07-30
DK1159965T3 (da) 2005-05-23
CA2156493C (en) 2002-10-29
BR9406666A (pt) 1996-01-23
KR100232833B1 (ko) 1999-12-01
EP1159965B1 (de) 2005-01-12
HUT72079A (en) 1996-03-28

Similar Documents

Publication Publication Date Title
PT894084E (pt) Derivados de acido cinamico e sua utilizacao como antagonistas de integrina
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
DE19375086I2 (de) Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
DE122004000041I1 (de) Therapeutische Zusammensetzungen die monoklonale Antikörper enthalten gegen den menschlichen Rezeptor für epidermalen Wachstumsfaktor.
ES2184858T3 (es) Cetoenoles alquil-dihalogenofenil substituidos como pesticidas y herbicidas.
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
BR9815340A (pt) Utilização de pelo menos um ativador dos receptores de tipo ppar-y.
ES2114605T3 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
GEP20074144B (en) Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
CA2203182A1 (en) Remedy for diseases caused by il-6 production
DE69935249D1 (de) Verwendung von at-1 rezeptorantagonisten oder at-2 rezeptormodulatoren zur behandlung von erkrankungen, die mit einer erhöhung an at-1 oder at-2 rezeptoren verbunden sind
ATE154245T1 (de) Verfahren zur zellwachstumshinderung und dazu nützliche verbindungen
ES2128629T3 (es) Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos.
ATE230993T1 (de) Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält
DE69434239D1 (de) Verwendung von Progesteronrezeptor Antagonisten zur Verhütung oder Behinderung der Fertilisation
ATE258438T1 (de) Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
NZ337601A (en) Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics by inhibiting IgE expression
ATE412670T1 (de) Parathyroid hormon (pth) polypeptidderivate
BR9906975A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero
AU555629B2 (en) Tetrazolyl substituted quinazolinones
ATE214921T1 (de) Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
ES543102A0 (es) Un procedimiento para la preparacion de un compuesto de qui-nazolinona
DK0379308T3 (da) Fremgangsmåde til selektivt at blokere 5HT2 receptorer
AU3024289A (en) The use of monoclonal antibodies (mabs) as procedure control for immunometric assays

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159965

Country of ref document: EP